Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (221-230 of 271) with videos related to

Pageof 28
Sort By:
Journal of the National Cancer Institute|May 3, 2020
Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational ResearchToni K Choueiri, Michael B Atkins, Ziad Bakouny, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinomaMohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Cancer Medicine|March 2, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew L Laccetti, Benjamin Garmezy, Lianchun Xiao, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinomaBrian I Rini, David F McDermott, Hans Hammers, et al.
BJU International|November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyAmishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Kidney cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
Nature Metabolism|January 28, 2020
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted TherapyYouqiong Ye, Qingsong Hu, Hu Chen, et al.
Clinical and Translational Medicine|May 25, 2023
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapyDaniel D Shapiro, Niki Millward Zacharias, Durga N Tripathi, et al.
Pageof 28

Showing results (221-230 of 271) with videos related to

Sort By:
Pageof 28
Journal of the National Cancer Institute|May 3, 2020
Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational ResearchToni K Choueiri, Michael B Atkins, Ziad Bakouny, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinomaMohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Cancer Medicine|March 2, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew L Laccetti, Benjamin Garmezy, Lianchun Xiao, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinomaBrian I Rini, David F McDermott, Hans Hammers, et al.
BJU International|November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyAmishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Kidney cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
Nature Metabolism|January 28, 2020
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted TherapyYouqiong Ye, Qingsong Hu, Hu Chen, et al.
Clinical and Translational Medicine|May 25, 2023
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapyDaniel D Shapiro, Niki Millward Zacharias, Durga N Tripathi, et al.
Pageof 28